nach oben

Erschienen in:

04.01.2022 | Original Contributions

Analysis of the Management of Cholelithiasis in Bariatric Surgery Patients: a Single-Center Experience

verfasst von: Carlos Gustavo Petrola Chacón, Ramón Vilallonga, Óscar González López, Amador García Ruiz de Gordejuela, Marc Beisani, Enric Caubet Busquet, Jose Manuel Fort, Manel Armengol Carrasco

Erschienen in: Obesity Surgery | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cholelithiasis is an issue in bariatric surgery patients. The incidence of cholelithiasis is increased in morbidly obese patients. After bariatric surgery, the management maybe sometimes challenging. There is no consensus about how to deal with cholelithiasis prior to bariatric surgery.

Materials and Methods

A retrospective review from our prospectively collected bariatric surgery database. Primary bariatric procedures from 2009 to 2020 were included. Prevalence of cholelithiasis and its management prior to bariatric surgery and the incidence and management of postoperative biliary events were analyzed.

Results

Over 1445 patients analyzed, preoperatively cholelithiasis was found in 153 (10.58%), and 68 out of them (44.44%) were symptomatic. Seventy-six patients had a concomitant cholecystectomy. In those cases, the bariatric procedure did not show increased operative time, length of stay, morbidity, or mortality compared to the rest of primary bariatric procedures. Twelve patients (15.58%) with previous cholelithiasis and no concomitant cholecystectomy presented any kind of biliary event and required cholecystectomy. De novo cholelithiasis rate requiring cholecystectomy was 3.86%. Postoperative biliary events both in de novo and persistent cholelithiasis population did not show any difference between the type of surgery, weight loss, and other characteristics.

Conclusions

Cholelithiasis was present in 10.58% of our primary bariatric surgery population. Concomitant cholecystectomy was safe in our series. Non-surgical management of asymptomatic cholelithiasis did not lead to a higher risk of postoperative biliary events. The global postoperative cholecystectomy rate was equivalent to the general population.

Graphical abstract

Obesity: preventing and managing the global epidemic. Report of a WHO consultation. vol. 894. Switzerland: 2000.

Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2014;384:766–81. https://doi.org/10.1016/S0140-6736(14)60460-8.CrossRefPubMedPubMedCentral

Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet (London, England). 2006;368:230–9. https://doi.org/10.1016/S0140-6736(06)69044-2.CrossRef

Krishna SG, Hinton A, Oza V, Hart PA, Swei E, El-Dika S, et al. Morbid obesity is associated with adverse clinical outcomes in acute pancreatitis: a propensity-matched study. Am J Gastroenterol. 2015;110:1608–19. https://doi.org/10.1038/ajg.2015.343.CrossRefPubMed

Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet (London, England). 2011;378:815–25. https://doi.org/10.1016/S0140-6736(11)60814-3.CrossRef

Warttig S, Ward S, Rogers G. Diagnosis and management of gallstone disease: summary of NICE guidance. BMJ (Clinical Research Ed). 2014;349:g6241. https://doi.org/10.1136/bmj.g6241.CrossRef

Villegas L, Schneider B, Provost D, Chang C, Scott D, Sims T, et al. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg. 2004;14:60–6. https://doi.org/10.1381/096089204772787301.CrossRefPubMed

Hamad GG, Ikramuddin S, Gourash WF, Schauer PR. Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait? Obes Surg. 2003;13:76–81. https://doi.org/10.1381/096089203321136638.CrossRefPubMed

Scott DJ, Villegas L, Sims TL, Hamilton EC, Provost DA, Jones DB. Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass. Surg Endosc. 2003;17:1796–802. https://doi.org/10.1007/s00464-002-8930-7.CrossRefPubMed

10.

Gustafsson U, Benthin L, Granström L, Groen AK, Sahlin S, Einarsson C. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. Hepatology (Baltimore, MD). 2005;41:1322–8. https://doi.org/10.1002/hep.20686.CrossRef

11.

Jonas E, Marsk R, Rasmussen F, Freedman J. Incidence of postoperative gallstone disease after antiobesity surgery: population-based study from Sweden. Surg Obes Relat Dis. 2010;6:54–8. https://doi.org/10.1016/j.soard.2009.03.221.CrossRefPubMed

12.

Tucker ON, Fajnwaks P, Szomstein S, Rosenthal RJ. Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery? Surg Endosc. 2008;22:2450–4. https://doi.org/10.1007/s00464-008-9769-3.CrossRefPubMed

13.

D’Hondt M, Sergeant G, Deylgat B, Devriendt D, van Rooy F, Vansteenkiste F. Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass? J Gastrointest Surg. 2011;15:1532–6. https://doi.org/10.1007/s11605-011-1617-4.CrossRefPubMed

14.

Tarantino I, Warschkow R, Steffen T, Bisang P, Schultes B, Thurnheer M. Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure?. A comparative cohort study. Obes Surg. 2011;21:1870–8. https://doi.org/10.1007/s11695-011-0495-x.CrossRefPubMed

15.

Ahmed AR, O’Malley W, Johnson J, Boss T. Cholecystectomy during laparoscopic gastric bypass has no effect on duration of hospital stay. Obes Surg. 2007;17:1075–9. https://doi.org/10.1007/s11695-007-9181-4.CrossRefPubMed

16.

Kim J-J, Schirmer B. Safety and efficacy of simultaneous cholecystectomy at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5:48–53. https://doi.org/10.1016/j.soard.2008.06.001.CrossRefPubMed

17.

Nougou A, Suter M. Almost routine prophylactic cholecystectomy during laparoscopic gastric bypass is safe. Obes Surg. 2008;18:535–9. https://doi.org/10.1007/s11695-007-9368-8.CrossRefPubMed

18.

Portenier DD, Grant JP, Blackwood HS, Pryor A, McMahon RL, DeMaria E. Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3:476–9. https://doi.org/10.1016/j.soard.2007.02.006.CrossRefPubMed

19.

Patel JA, Patel NA, Piper GL, Smith DE 3rd, Malhotra G, Colella JJ. Perioperative management of cholelithiasis in patients presenting for laparoscopic Roux-en-Y gastric bypass: have we reached a consensus? Am Surg. 2009;75:470–6 (discussion 476).CrossRef

20.

Ellner SJ, Myers TT, Piorkowski JR, Mavanur AA, Barba CA. Routine cholecystectomy is not mandatory during morbid obesity surgery. Surg Obes Relat Dis. 2007;3:456–60. https://doi.org/10.1016/j.soard.2006.11.008.CrossRefPubMed

21.

Patel KR, White SC, Tejirian T, Han SH, Russell D, Vira D, et al. Gallbladder management during laparoscopic Roux-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary. Am Surg. 2006;72:857–61.CrossRef

22.

Papasavas PK, Gagné DJ, Ceppa FA, Caushaj PF. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2:41–7. https://doi.org/10.1016/j.soard.2005.10.006.CrossRefPubMed

23.

Tucker O, Soriano I, Szomstein S, Rosenthal R. Management of choledocholithiasis after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008;4:674–8. https://doi.org/10.1016/j.soard.2008.01.014.CrossRefPubMed

24.

Fuller W, Rasmussen JJ, Ghosh J, Ali MR. Is routine cholecystectomy indicated for asymptomatic cholelithiasis in patients undergoing gastric bypass? Obes Surg. 2007;17:747–51. https://doi.org/10.1007/s11695-007-9138-7.CrossRefPubMed

25.

Swartz DE, Felix EL. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients? Surg Obes Relat Dis. 2005;1:555–60. https://doi.org/10.1016/j.soard.2005.08.002.CrossRefPubMed

26.

Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology (Baltimore, MD). 2013;58:2133–41. https://doi.org/10.1002/hep.26563.CrossRef

27.

Kiani Q, Farooqui F, Khan MS, Khan AZ, Nauman Tariq M, Akhtar A. Association of body mass index and diet with symptomatic gall stone disease: a case-control study. Cureus. 2020;12:e7188. https://doi.org/10.7759/cureus.7188.CrossRefPubMedPubMedCentral

28.

Wanjura V, Szabo E, Österberg J, Ottosson J, Enochsson L, Sandblom G. Morbidity of cholecystectomy and gastric bypass in a national database. Br J Surg. 2018;105:121–7. https://doi.org/10.1002/bjs.10666.CrossRefPubMed

29.

Dorman RB, Zhong W, Abraham AA, Ikramuddin S, Al-Refaie WB, Leslie DB, et al. Does concomitant cholecystectomy at time of Roux-en-Y gastric bypass impact adverse operative outcomes? Obes Surg. 2013;23:1718–26. https://doi.org/10.1007/s11695-013-1001-4.CrossRefPubMed

30.

Conley A, Tarboush M, Manatsathit W, Meguid A, Szpunar S, Hawasli A. Do gallstones found before sleeve gastrectomy behave the same as those formed after surgery due to weight loss? Am J Surg. 2016;212:931–4. https://doi.org/10.1016/j.amjsurg.2016.01.039.CrossRefPubMed

31.

Fobi M, Lee H, Igwe D, Felahy B, James E, Stanczyk M, et al. Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg. 2002;12:350–3. https://doi.org/10.1381/096089202321088138.CrossRefPubMed

32.

Dittrick GW, Thompson JS, Campos D, Bremers D, Sudan D. Gallbladder pathology in morbid obesity. Obes Surg. 2005;15:238–42. https://doi.org/10.1381/0960892053268273.CrossRefPubMed

33.

O’Brien PE, Dixon JB. A rational approach to cholelithiasis in bariatric surgery: its application to the laparoscopically placed adjustable gastric band. Arch Surg (Chicago, Ill : 1960). 2003;138:908–12. https://doi.org/10.1001/archsurg.138.8.908.CrossRef

34.

Taylor J, Leitman IM, Horowitz M. Is routine cholecystectomy necessary at the time of Roux-en-Y gastric bypass? Obes Surg. 2006;16:759–61. https://doi.org/10.1381/096089206777346781.CrossRefPubMed

35.

Guadalajara H, Sanz Baro R, Pascual I, Blesa I, Rotundo GS, López JMG, et al. Is prophylactic cholecystectomy useful in obese patients undergoing gastric bypass? Obes Surg. 2006;16:883–5. https://doi.org/10.1381/096089206777822287.CrossRefPubMed

36.

Sioka E, Zacharoulis D, Zachari E, Papamargaritis D, Pinaka O, Katsogridaki G, et al. Complicated gallstones after laparoscopic sleeve gastrectomy. J Obes. 2014;2014:468203. https://doi.org/10.1155/2014/468203.CrossRefPubMedPubMedCentral

37.

Liem RK, Niloff PH. Prophylactic cholecystectomy with open gastric bypass operation. Obes Surg. 2004;14:763–5. https://doi.org/10.1381/0960892041590746.CrossRefPubMed

38.

Warschkow R, Tarantino I, Ukegjini K, Beutner U, Güller U, Schmied BM, et al. Concomitant cholecystectomy during laparoscopic Roux-en-Y gastric bypass in obese patients is not justified: a meta-analysis. Obes Surg. 2013;23:397–407. https://doi.org/10.1007/s11695-012-0852-4.CrossRefPubMed

39.

Festi D, Reggiani MLB, Attili AF, Loria P, Pazzi P, Scaioli E, et al. Natural history of gallstone disease: expectant management or active treatment? Results from a population-based cohort study. J Gastroenterol Hepatol. 2010;25:719–24. https://doi.org/10.1111/j.1440-1746.2009.06146.x.CrossRefPubMed

40.

Schmidt M, Hausken T, Glambek I, Schleer C, Eide GE, Søndenaa K. A 24-year controlled follow-up of patients with silent gallstones showed no long-term risk of symptoms or adverse events leading to cholecystectomy. Scand J Gastroenterol. 2011;46:949–54. https://doi.org/10.3109/00365521.2011.571710.CrossRefPubMed

41.

Halldestam I, Enell E-L, Kullman E, Borch K. Development of symptoms and complications in individuals with asymptomatic gallstones. Br J Surg. 2004;91:734–8. https://doi.org/10.1002/bjs.4547.CrossRefPubMed

42.

Yardimci S, Coskun M, Demircioglu S, Erdim A, Cingi A. Is concomitant cholecystectomy necessary for asymptomatic cholelithiasis during laparoscopic sleeve gastrectomy? Obes Surg. 2018;28:469–73. https://doi.org/10.1007/s11695-017-2867-3.CrossRefPubMed

43.

Tustumi F, Bernardo WM, Santo MA, Cecconello I. Cholecystectomy in patients submitted to bariatric procedure: a systematic review and meta-analysis. Obes Surg. 2018;28:3312–20. https://doi.org/10.1007/s11695-018-3443-1.CrossRefPubMed

44.

Martinez J, Guerrero L, Byers P, Lopez P, Scagnelli T, Azuaje R, et al. Endoscopic retrograde cholangiopancreatography and gastroduodenoscopy after Roux-en-Y gastric bypass. Surg Endosc. 2006;20:1548–50. https://doi.org/10.1007/s00464-005-0267-6.CrossRefPubMed

45.

Mosler P, Fogel EL. Massive subcutaneous emphysema after attempted endoscopic retrograde cholangiopancreatography in a patient with a history of bariatric gastric bypass surgery. Endoscopy. 2007;39(Suppl 1):E155. https://doi.org/10.1055/s-2006-925181.CrossRefPubMed

46.

Patel JA, Patel NA, Shinde T, Uchal M, Dhawan MK, Kulkarni A, et al. Endoscopic retrograde cholangiopancreatography after laparoscopic Roux-en-Y gastric bypass: a case series and review of the literature. Am Surg. 2008;74:684–9.

47.

Vilallonga R, Pimentel R, Rosenthal RJ. Hybrid endolaparoscopic management of biliary tract pathology in bariatric patients after gastric bypass: case report and review of a single-institution experience. Surg Laparosc Endosc Percutan Tech. 2013;23:e188–90. https://doi.org/10.1097/SLE.0b013e31828b85e8.CrossRefPubMed

48.

Wang TJ, Cortes P, Jirapinyo P, Thompson CC, Ryou M. A comparison of clinical outcomes and cost utility among laparoscopy, enteroscopy, and temporary gastric access-assisted ERCP in patients with Roux-en-Y gastric bypass anatomy. Surg Endosc. 2020;35:4469–77. https://doi.org/10.1007/s00464-020-07952-3.CrossRefPubMed

49.

Coupaye M, Castel B, Sami O, Tuyeras G, Msika S, Ledoux S. Comparison of the incidence of cholelithiasis after sleeve gastrectomy and Roux-en-Y gastric bypass in obese patients: a prospective study. Surg Obes Relat Dis. 2015;11:779–84. https://doi.org/10.1016/j.soard.2014.10.015.CrossRefPubMed

50.

Tsirline VB, Keilani ZM, el Djouzi S, Phillips RC, Kuwada TS, Gersin K, et al. How frequently and when do patients undergo cholecystectomy after bariatric surgery? Surg Obes Relat Dis. 2014;10:313–21. https://doi.org/10.1016/j.soard.2013.10.011.CrossRefPubMed

51.

Moon RC, Teixeira AF, DuCoin C, Varnadore S, Jawad MA. Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding. Surg Obes Relat Dis. 2014;10:64–8. https://doi.org/10.1016/j.soard.2013.04.019.CrossRefPubMed

52.

Li VKM, Pulido N, Martinez-Suartez P, Fajnwaks P, Jin HY, Szomstein S, et al. Symptomatic gallstones after sleeve gastrectomy. Surg Endosc. 2009;23:2488–92. https://doi.org/10.1007/s00464-009-0422-6.CrossRefPubMed

53.

Plecka Östlund M, Wenger U, Mattsson F, Ebrahim F, Botha A, Lagergren J. Population-based study of the need for cholecystectomy after obesity surgery. Br J Surg. 2012;99:864–9. https://doi.org/10.1002/bjs.8701.CrossRefPubMed

54.

Chen J-H, Tsai M-S, Chen C-Y, Lee H-M, Cheng C-F, Chiu Y-T, et al. Bariatric Surgery Did Not Increase the Risk of Gallstone Disease in Obese Patients: a Comprehensive Cohort Study. Obes Surg. 2019;29:464–73. https://doi.org/10.1007/s11695-018-3532-1.CrossRefPubMed

55.

Haal S, Rondagh D, Hutten BA, Acherman YIZ, van de Laar AWJM, Huijgen R, et al. Risk factors for cholecystectomy after laparoscopic Roux-En-Y gastric bypass. Obes Surg. 2020;30:507–14. https://doi.org/10.1007/s11695-019-04166-y.CrossRefPubMed

Titel: Analysis of the Management of Cholelithiasis in Bariatric Surgery Patients: a Single-Center Experience
verfasst von: Carlos Gustavo Petrola Chacón
Ramón Vilallonga
Óscar González López
Amador García Ruiz de Gordejuela
Marc Beisani
Enric Caubet Busquet
Jose Manuel Fort
Manel Armengol Carrasco
Publikationsdatum: 04.01.2022
Verlag: Springer US
Erschienen in: Obesity Surgery / Ausgabe 3/2022
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-021-05883-z

Neu im Fachgebiet Chirurgie

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO₂-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Analysis of the Management of Cholelithiasis in Bariatric Surgery Patients: a Single-Center Experience